Prism Capital Corporation: A US-based private equity firm offering asset management and advisory services.
Location
Chicago, IL, US
Founded
1999
Prism Capital, a Chicago-based private equity firm, focused on growth equity and lower-middle market subordinated debt investments. The firm managed two main funds: the Prism Opportunity Fund for growth equity and the Prism Mezzanine Fund for subordinated debt. Prism Capital primarily operated in the United States, offering asset management and advisory services.
Notable portfolio companies included SecurePipe (merged with Trustwave), Celleration (sold to Alliqua BioMedical), HighBeam Research (sold to Gale), and SterilMed. The firm demonstrated expertise in various sectors, including digital security, medical devices, and research services. Prism Capital's investment strategy focused on identifying promising companies with growth potential across diverse industries.
Prism Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of disclosed investments by stage.
